Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam J N Raymakers

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
The American Journal of Cardiology|August 29, 2016
Inclusion Criteria May Significantly Bias Study ResultsAdam J N Raymakers, Larry D Lynd
BMJ (Clinical Research Ed.)|June 22, 2022
Promoting confidence in cost-effectiveness analysesAdam J N Raymakers, Aaron S Kesselheim
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 7, 2026
Conflicts of Interest in FDA Advisory Committees: A Systematic Literature ReviewArianna Gentilini, Adam J N Raymakers, Leah Z Rand
Cancer|September 24, 2019
Health-related quality of life in oncology drug reimbursement submissions in Canada: A review of submissions to the pan-Canadian Oncology Drug ReviewAdam J N Raymakers, Dean A Regier, Stuart J Peacock
JAMA Dermatology|September 18, 2024
Estimating Costs in Beremagene Geperpavec for Dystrophic Epidermolysis Bullosa-ReplyAdam J N Raymakers, Aaron S Kesselheim, William B Feldman
Journal of Cancer Policy|May 13, 2022
Experiences and perspectives of individuals accessing CAR-T cell therapy: A qualitative analysis of online Reddit discussionsKristina Jenei, Michael Burgess, Stuart Peacock, et al.
Pharmacoeconomics|December 29, 2011
Economic and humanistic burden of external genital wartsAdam J N Raymakers, Mohsen Sadatsafavi, Fawziah Marra, et al.
Current Oncology (Toronto, Ont.)|June 2, 2021
Cost-Effectiveness Analysis of Stereotactic Ablative Body Radiotherapy for the Treatment of Oligometastatic Tumors versus Standard of CareAdam J N Raymakers, David Cameron, Scott Tyldesley, et al.
Journal of Thoracic Imaging|July 13, 2013
Diagnostic strategies incorporating computed tomography angiography for pulmonary embolism: a systematic review of cost-effectiveness analysesAdam J N Raymakers, John Mayo, Carlo A Marra, et al.
The Patient|September 3, 2020
Genomic Testing for Relapsed and Refractory Lymphoid Cancers: Understanding Patient ValuesSarah Costa, Dean A Regier, Adam J N Raymakers, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
The American Journal of Cardiology|August 29, 2016
Inclusion Criteria May Significantly Bias Study ResultsAdam J N Raymakers, Larry D Lynd
BMJ (Clinical Research Ed.)|June 22, 2022
Promoting confidence in cost-effectiveness analysesAdam J N Raymakers, Aaron S Kesselheim
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 7, 2026
Conflicts of Interest in FDA Advisory Committees: A Systematic Literature ReviewArianna Gentilini, Adam J N Raymakers, Leah Z Rand
Cancer|September 24, 2019
Health-related quality of life in oncology drug reimbursement submissions in Canada: A review of submissions to the pan-Canadian Oncology Drug ReviewAdam J N Raymakers, Dean A Regier, Stuart J Peacock
JAMA Dermatology|September 18, 2024
Estimating Costs in Beremagene Geperpavec for Dystrophic Epidermolysis Bullosa-ReplyAdam J N Raymakers, Aaron S Kesselheim, William B Feldman
Journal of Cancer Policy|May 13, 2022
Experiences and perspectives of individuals accessing CAR-T cell therapy: A qualitative analysis of online Reddit discussionsKristina Jenei, Michael Burgess, Stuart Peacock, et al.
Pharmacoeconomics|December 29, 2011
Economic and humanistic burden of external genital wartsAdam J N Raymakers, Mohsen Sadatsafavi, Fawziah Marra, et al.
Current Oncology (Toronto, Ont.)|June 2, 2021
Cost-Effectiveness Analysis of Stereotactic Ablative Body Radiotherapy for the Treatment of Oligometastatic Tumors versus Standard of CareAdam J N Raymakers, David Cameron, Scott Tyldesley, et al.
Journal of Thoracic Imaging|July 13, 2013
Diagnostic strategies incorporating computed tomography angiography for pulmonary embolism: a systematic review of cost-effectiveness analysesAdam J N Raymakers, John Mayo, Carlo A Marra, et al.
The Patient|September 3, 2020
Genomic Testing for Relapsed and Refractory Lymphoid Cancers: Understanding Patient ValuesSarah Costa, Dean A Regier, Adam J N Raymakers, et al.
Pageof 4